Pennant leaders tout record breaking’ home health growth, transformative deals

Pennant leaders tout record breaking’ home health growth, transformative deals 
Home Health Care News; by Audrie Martin; 2/28/25 
Describing a year of “record breaking performance” for Pennant Group (Nasdaq: PNTG), leaders with the organization touted the home health segment in particular during the company’s Q4 2024 earnings call on Friday. ... Total home health admissions reached 59,741, which represented an increase of 37.3% over the prior year.  ... Pennant’s home health and hospice segment saw substantial revenue growth, reporting an increase of $125 million for the year compared to 2023. In the fourth quarter alone, revenue rose by $35.1 million, reaching $142 million. ... [Pennant] completed numerous strategic home health and hospice acquisitions. ... Pennant is looking for more deals but will likely be more active in the second half of the year.